CFTC Issues No-Action Letter for DCMs Regarding Converting Existing Perpetual-Style Broad-Based Security Index Futures into True Perpetual Futures

The CFTC’s Division of Market Oversight issued no-action relief allowing designated contract markets to remove expiration dates from existing perpetual-style broad-based security index futures and convert them into true perpetual futures, subject to customer-protection and procedural conditions. DCMs must solicit feedback from customers with open positions, provide advance notice and an opportunity to exit, disclose risks, avoid other material term changes, and file amendments under Regulations 40.5 or 40.6. The relief expires October 20, 2026.

Analysis

The investable signal is regulatory optionality, not near-term earnings. Removing expiry could make regulated U.S. index exposure easier to hold continuously, potentially drawing activity from offshore perpetual products and shifting demand away from expiring index futures. But this may be substitution rather than incremental volume: perpetual contracts could cannibalize listed futures and their roll-related activity, while the economic impact depends on contract design, fees, liquidity, and customer uptake—none is established here.

The relief’s short validity window makes exchange filings and implementation the immediate catalysts; failure to meet procedural conditions, or lack of exchange action before expiry, would sharply reduce the signal. Over 1–3 months, monitor DCM filings, launch/conversion notices, open interest, and volume mix. Over 6–18 months, broader adoption could strengthen regulated venues’ competitiveness, but only if the contracts offer credible price anchoring and users accept the disclosures and operational risks. CME Group and Cboe Global Markets are relevant venue operators to monitor, not confirmed participants. A key contrarian point: a more convenient wrapper need not expand total derivatives demand, and could simply redistribute it. No company-level revenue case is yet supported.

Key Decisions for Investors

• No immediate directional trade on exchange operators. Treat CME Group and Cboe Global Markets as watch-list names pending confirmation of participation, contract terms, and evidence of incremental—not merely migrated—open interest or fees.
• Over the next two weeks, monitor DCM filings and customer notices. Reassess only if a venue confirms conversion and provides enough detail to evaluate pricing, margin, liquidity, and how the contract maintains alignment with the underlying index.
• Falsify the adoption thesis if no qualifying filings or conversion plans emerge before the relief expires, or if post-launch data show activity shifting from existing listed futures without growth in aggregate index-derivatives activity.